| 000 | 01634 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250514023723.0 | ||
| 264 | 0 | _c20020423 | |
| 008 | 200204s 0 0 eng d | ||
| 022 | _a0925-5710 | ||
| 024 | 7 |
_a10.1007/BF02981987 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCarr, Marcus E | |
| 245 | 0 | 0 |
_aSuccessful use of recombinant factor VIIa for hemostasis during total knee replacement in a severe hemophiliac with high-titer factor VIII inhibitor. _h[electronic resource] |
| 260 |
_bInternational journal of hematology _cJan 2002 |
||
| 300 |
_a95-9 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aArthroplasty, Replacement, Knee |
| 650 | 0 | 4 | _aBlood Loss, Surgical |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 |
_aFactor VIII _ximmunology |
| 650 | 0 | 4 |
_aFactor VIIa _xadministration & dosage |
| 650 | 0 | 4 |
_aHemarthrosis _xetiology |
| 650 | 0 | 4 |
_aHemophilia A _xcomplications |
| 650 | 0 | 4 | _aHemostasis, Surgical |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfusions, Intravenous |
| 650 | 0 | 4 |
_aIsoantibodies _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aPostoperative Hemorrhage _xdrug therapy |
| 650 | 0 | 4 | _aPremedication |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aTourniquets |
| 700 | 1 | _aLoughran, Thomas P | |
| 700 | 1 | _aCardea, John A | |
| 700 | 1 | _aSmith, Wade K | |
| 700 | 1 | _aKuhn, Jan G | |
| 700 | 1 | _aDottore, Maribeth V | |
| 773 | 0 |
_tInternational journal of hematology _gvol. 75 _gno. 1 _gp. 95-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF02981987 _zAvailable from publisher's website |
| 999 |
_c11752077 _d11752077 |
||